CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

With the debut of CWENCH Hydration™ in its first major Canadian grocer, Cizzle Brands anticipates that it will be able to further penetrate the mainstream consumer market alongside the specialty athletic and fitness-related markets. Starting this month, CWENCH Hydration™ mix packets will be offered in the pharmacy section of 47 Metro supermarkets across the province of Ontario.

Cizzle Brands Corporation (Cboe Canada: CZZL) ( the "Company or "Cizzle Brands") is pleased to announce that its flagship product CWENCH Hydration™ is launching in supermarkets operated under the Metro banner in Ontario, operated by the Metro, Inc. parent company. Initially, the pharmacy sections of 47 Metro supermarkets will be carrying CWENCH Hydration™ mix packets, sold in a 10-count format, which will be available in-store by the end of January 2025.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109944605/en/

10-count packs of CWENCH Hydration™ mix will be sold in the pharmacy section of 47 Metro supermarkets in Ontario by the end of January 2025. (Photo: Business Wire)

10-count packs of CWENCH Hydration™ mix will be sold in the pharmacy section of 47 Metro supermarkets in Ontario by the end of January 2025. (Photo: Business Wire)

This launch complements CWENCH Hydration™'s existing retail footprint in major Canadian chain retailers which includes Sport Chek, Canadian Tire, and Source for Sports, as detailed in Cizzle Brands' January 7, 2025 press release. Following this launch, CWENCH Hydration™ will be sold in more than 1,300 points of sale across Canada, the United States, and Europe.

The launch of CWENCH Hydration™ in Metro's Ontario supermarkets will mark the brand's first entry into the Canadian large-chain grocery market segment, which Cizzle Brands expects to help bolster mainstream adoption of CWENCH Hydration™ products.

To drive visibility of CWENCH Hydration™, Cizzle Brands will be working with Metro to provide training resources and materials for employees to improve conversion rates. Cizzle Brands also plans to provide ancillary marketing support to promote awareness of CWENCH Hydration's availability in Metro supermarkets.

As of September 28, 2024, Metro operates 995 stores primarily in Ontario and Quebec under banners including Metro , Metro Plus , Food Basics , and Super C . More information about Metro can be found on its website: https://www.metro.ca/

Cizzle Brands Chairman and Chief Executive Officer, John Celenza, commented, "Here in Ontario, Metro is one of the most recognized names in the grocery category, and so we are very pleased that Metro is beginning to stock CWENCH Hydration™ products in its Ontario stores so shortly after we first launched the brand. Our objective is to turn CWENCH Hydration™ into a household name that is recognized as a better hydration option for athletes of all ages, and we believe that availability at Metro supermarkets will be a key step towards that. We look forward to working together to make this new-found partnership a productive and fruitful long-term business relationship."

About Cizzle Brands Corporation

Cizzle Brands is elevating the game in health and wellness. Through extensive collaboration and testing with leading athletes and trainers across several elite sports, Cizzle Brands launched CWENCH Hydration in May of 2024, a better-for-you sports nutrition beverage that is now carried in over 1,200 stores in Canada, the United States, and Europe. CWENCH Hydration is tailored to help people achieve their best in both competitive sports and in living a healthy, vibrant, active lifestyle.

For more information about Cizzle Brands, please visit: https://www.cizzlebrands.com/

For more information about CWENCH, please visit: https://cwenchhydration.com/

On behalf of the Board of Directors of the Company,

Cizzle Brands Corporation

"John Celenza"

John Celenza, Chief Executive Officer

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" which may include, but is not limited to, information with respect to the activities, events or developments that the Company expects or anticipates will or may occur in the future, such as, but not limited to: the listing of the Company's common shares on the Cboe Canada; the timing of the commencement of trading of the common shares; and new products of the Company. Such forward-looking information is often, but not always, identified by the use of words and phrases such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company.

Forward looking information involves known and unknown risks, uncertainties and other risk factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such risks include risks related to increased competition and current global financial conditions, access and supply risks, reliance on key personnel, operational risks, regulatory risks, financing, capitalization and liquidity risks. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. The Company undertakes no obligation, except as otherwise required by law, to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors change.

Readers using news aggregation services may be unable to view the media. Please access SEDAR+ or the Investors section of the Company's website for a version of this press release containing all published media.

For further information, please contact:

Setti Coscarella
Head of Corporate Development
investors@cizzlebrands.com
1-844-588-2088

News Provided by Business Wire via QuoteMedia

CZZL:AQL
The Conversation (0)
Cizzle Brands Corporation

Cizzle Brands Corporation

Cizzle Brands Corporation is elevating the game in health & wellness. Its first product, CWENCH Hydration, which is now available across Canada, is the result of extensive collaboration and testing with leading athletes and trainers across various elite sports. CWENCH delivers clean, performing hydration, tailored to empower peak performance in both competitive sports and those living a healthy, vibrant, active lifestyle.
CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

CWENCH Hydration Gains Distribution in Metro Supermarkets Across Ontario

With the debut of CWENCH Hydration™ in its first major Canadian grocer, Cizzle Brands anticipates that it will be able to further penetrate the mainstream consumer market alongside the specialty athletic and fitness-related markets. Starting this month, CWENCH Hydration™ mix packets will be offered in the pharmacy section of 47 Metro supermarkets across the province of Ontario.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Row of test tubes and pipette with chemical droplet chemical coming from it.

Top 5 Small-cap Biotech Stocks (Updated January 2025)

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three-year highs in response to breakthrough innovations and increased deals for biotech stocks on the NASDAQ.

After dropping to a low of 3,637.05 in October 2023, the index climbed to a high of 4,954.813 on September 19, 2024. While the NBI is trading down at 4,399.36 as of January 7, 2025, further growth could be in store in the future. However, the current economic environment means the biotech sector may have a complex road ahead.

According to a recent report from Precedence Research, the global biotech market is expected to grow at a compound annual growth rate of 11.5 percent from now to 2034, reaching a valuation of US$4.61 trillion.

Keep reading...Show less

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January 13, 2025 . Robert A. Bradway chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

Amgen (NASDAQ:AMGN) will present at the 2025 J.P. Morgan Healthcare Conference at 3:00 p.m. PT on Monday, January 13, 2025 . Robert A. Bradway chairman and chief executive officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
A cosmetic product developed from natural proteins using biotechnology.

The Future of Biotech: Innovations in Glycobiology

Glycobiology is rapidly emerging as a promising investment frontier within the biotech industry, offering novel solutions in pharmaceuticals and cosmetics.

Recent breakthroughs in carbohydrate-based technologies are attracting significant attention from investors and industry leaders alike. Companies specializing in glycobiology are developing innovative approaches to meet the growing demand for safe and effective medical treatments and cosmetic products.

This robust growth trajectory, driven by increasing investments in research and development, government funding and rising demand for carbohydrate-based therapies, presents a unique opportunity for investors seeking high growth potential in a niche sector with substantial barriers to entry.

Keep reading...Show less

Latest Press Releases

Related News

×